Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 6.729
Filtrer
1.
Dermatol Online J ; 30(3)2024 Jun 15.
Article de Anglais | MEDLINE | ID: mdl-39090047

RÉSUMÉ

are that the contents of this article are their own original unpublished findings. Title: Comparison of potential contact allergens in best-selling adult and baby cleansers Authors: Jayden Galamgam1 MD, Sasan D Noveir2 BA, Carol E Cheng1 MD Affiliations: 1Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA, 2 David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA Corresponding Author: Jayden Galamgam MD, Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, Email: jgalamgam@mednet.ucla.edu.


Sujet(s)
Allergènes , Humains , Allergènes/effets indésirables , Eczéma de contact allergique/étiologie , Adulte , Nourrisson , Détergents/effets indésirables
2.
BMC Infect Dis ; 24(1): 794, 2024 Aug 07.
Article de Anglais | MEDLINE | ID: mdl-39112970

RÉSUMÉ

BACKGROUND: COVID-19 is a new infectious disease. To investigate whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection increases the adverse reactions of subcutaneous specific immunotherapy (SCIT) in children. METHODS: This study was conducted by collecting relevant data from children who underwent house dust mite SCIT from April 3, 2021, to March 18, 2023, including information on the time of COVID-19 infection, symptoms, and adverse reactions after each allergen injection. A mixed effects model was used to analyze the changes in adverse reactions before and after the COVID-19 infection. RESULTS: Among the records of adverse reactions from 2658 injections in 123 children who underwent SCIT, the overall adverse reaction rate before COVID-19 infection was 39.8% and 30.0% after COVID-19 infection. Compared with pre-infection with COVID-19, the risks of overall adverse reactions, local adverse reactions, and systemic adverse reactions of immunotherapy after COVID-19 infection were reduced (odds ratio [OR] = 0.24, 0.31, and 0.28, all P < 0.05). Among the local adverse reactions, the incidence of the unvaccinated group was the highest (15.3% vs. 7.1%). The incidence of overall and local adverse reactions to SCIT decreased in 2-vaccinated COVID-19 recipients (OR = 0.29-0.31, P < 0.05). CONCLUSIONS: In children, SARS-CoV-2 infection does not increase the incidence of adverse reactions to SCIT. This finding can provide a basis for the implementation of allergen-specific immunotherapy (AIT) during the COVID-19 pandemic.


Sujet(s)
COVID-19 , Désensibilisation immunologique , SARS-CoV-2 , Humains , COVID-19/thérapie , COVID-19/immunologie , Enfant , Études rétrospectives , Mâle , Femelle , Enfant d'âge préscolaire , SARS-CoV-2/immunologie , Injections sous-cutanées , Désensibilisation immunologique/effets indésirables , Désensibilisation immunologique/méthodes , Adolescent , Animaux , Pyroglyphidae/immunologie , Allergènes/immunologie , Allergènes/effets indésirables , Allergènes/administration et posologie , Nourrisson
3.
Acta Derm Venereol ; 104: adv40332, 2024 Aug 14.
Article de Anglais | MEDLINE | ID: mdl-39140486

RÉSUMÉ

Fragrance materials are widely used in various types of products in daily life and many of them can be contact sensitizers. Contact allergy to fragrances has been reported to be common worldwide. Unlike other groups of contact allergens such as metals and preservatives, fragrance materials in consumer products can be present as single fragrance chemicals or in the form of mixtures known as natural complex substances. Due to the complexity of the fragrance materials and the high number of fragrance substances known to cause contact sensitization, selecting suitable materials for patch testing is challenging. Emerging fragrance markers have been additionally introduced in different baseline series for screening to enhance the rate of fragrance contact allergy detection. Moreover, there have been continual updates on basic knowledge, clinical perspectives, sources of exposure, and regulations on the use of fragrance materials. Avoiding pitfalls while performing patch testing with fragrance test materials is also crucial and should not be overlooked. Therefore, this review aims to update knowledge to provide a high-quality holistic approach to fragrance contact allergy diagnosis and management.


Sujet(s)
Allergènes , Eczéma de contact allergique , Tests épicutanés , Parfum , Humains , Eczéma de contact allergique/diagnostic , Eczéma de contact allergique/étiologie , Parfum/effets indésirables , Allergènes/effets indésirables , Valeur prédictive des tests
4.
Eur Respir Rev ; 33(172)2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-39009406

RÉSUMÉ

Paediatric populations are particularly vulnerable to respiratory diseases caused and exacerbated by aeroallergens, pollutants and infectious agents. Worsening climate change is expected to increase the prevalence of pollutants and aeroallergens while amplifying disease severity and causing disproportionate effects in under-resourced areas. The purpose of this narrative review is to summarise the role of anthropogenic climate change in the literature examining the future impact of aeroallergens, pollutants and infectious agents on paediatric respiratory diseases with a focus on equitable disease mitigation. The aeroallergens selected for discussion include pollen, dust mites and mould as these are prevalent triggers of paediatric asthma worldwide. Human rhinovirus and respiratory syncytial virus are key viruses interacting with climate change and pollution and are primary causal agents of viral respiratory disease. Within this review, we present the propensity for aeroallergens, climate change and pollution to synergistically exacerbate paediatric respiratory disease and outline measures that can ameliorate the expected increase in morbidity and severity of disease through a health equity lens. We support shifting from fossil fuels to renewable energy worldwide, across sectors, as a primary means of reducing increases in morbidity.


Sujet(s)
Polluants atmosphériques , Allergènes , Changement climatique , Exposition environnementale , Humains , Allergènes/effets indésirables , Allergènes/immunologie , Polluants atmosphériques/effets indésirables , Polluants atmosphériques/immunologie , Enfant , Exposition environnementale/effets indésirables , Facteurs de risque , Appréciation des risques , Pollution de l'air/effets indésirables , Maladies de l'appareil respiratoire/épidémiologie , Maladies de l'appareil respiratoire/étiologie , Exposition par inhalation/effets indésirables , Enfant d'âge préscolaire , Facteurs âges , Adolescent , Nourrisson , Animaux , Nouveau-né , Santé de l'enfant
5.
Article de Anglais | MEDLINE | ID: mdl-39019615

RÉSUMÉ

BACKGROUND: Exposure to fine particulate matter (PM2.5) has been associated with allergic diseases, including asthma. However, information about the effects of specific PM2.5 components is limited. This study aimed to investigate the relationship of exposure to chemical components of PM2.5 during pregnancy and early childhood with the development of asthma, allergies, and sensitization in school-age children. METHODS: This study included 2,408 children in the second grade of elementary school. Questionnaire surveys of respiratory/allergic symptoms and measurements of serum total IgE and specific IgE levels to house dust mite (HDM) and animal proteins were conducted. Exposures to ambient PM2.5 mass, sulfate (SO42-), nitrate (NO3-), ammonium (NH4+), elemental carbon (EC), and organic carbon (OC) of PM2.5 in participants' residences from conception to age six were estimated using predictive models. Multiple logistic regression analysis was used to analyze the association of respiratory/allergic symptoms and allergen sensitization with estimated exposure concentrations, after adjustment for survey year, sex, season of birth, feeding method during infancy, presence of siblings, history of lower respiratory tract infection, use of childcare facilities, passive smoking, presence of pets, mother's age, history of allergic diseases, smoking during pregnancy, and annual household income. RESULTS: No significant association was found between PM2.5 and its component concentrations and asthma. However, wheezing significantly increased with mean NO3- concentrations during pregnancy (odds ratio of 1.64 [95% confidence interval: 1.10, 2.47] for an interquartile range increase). Significant associations were also found between EC in the second trimester of pregnancy and PM2.5, NO3-, EC, and OC concentrations in early childhood. Higher PM2.5, SO4-, and NH4+ concentrations during the second trimester increased the risk of rhinitis. Sensitizations to HDM and animal proteins were significantly associated with exposure to components such as SO42- and NH4+ during pregnancy but not with postnatal exposure. CONCLUSIONS: Exposures to NO3-, EC, and OC during pregnancy and early childhood were associated with wheezing. SO42- and NH4+ exposures during pregnancy were associated with sensitization to HDM and animal proteins. Asthma was not associated with exposure to PM2.5 and its main components at any period.


Sujet(s)
Polluants atmosphériques , Asthme , Hypersensibilité , Matière particulaire , Effets différés de l'exposition prénatale à des facteurs de risque , Humains , Matière particulaire/analyse , Matière particulaire/effets indésirables , Femelle , Grossesse , Asthme/épidémiologie , Asthme/étiologie , Asthme/induit chimiquement , Enfant , Mâle , Polluants atmosphériques/analyse , Polluants atmosphériques/effets indésirables , Effets différés de l'exposition prénatale à des facteurs de risque/épidémiologie , Hypersensibilité/épidémiologie , Hypersensibilité/étiologie , Immunoglobuline E/sang , Exposition environnementale/effets indésirables , Chine/épidémiologie , Exposition maternelle/effets indésirables , Exposition maternelle/statistiques et données numériques , Animaux , Allergènes/immunologie , Allergènes/analyse , Allergènes/effets indésirables
6.
Pediatr Allergy Immunol ; 35(7): e14185, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38949074

RÉSUMÉ

BACKGROUND: Few studies have assessed the nature of accidental allergic reactions (AAR). We assessed the prevalence and risk factors for AAR in Japanese children. METHODS: This study included children with immediate-type hen's egg (HE), cow's milk (CM), wheat, or peanut allergy who developed allergic reactions within at least 2 years and were followed up regularly at a single national allergy center in Japan. From January to December 2020, low-dose reactivity was defined as allergic reactions to ≤250, ≤102, ≤53, or ≤ 133 mg of HE, CM, wheat, or peanut protein, respectively. The annualized AAR rate showed the number of reactions per patient per year (95% confidence interval). AAR risk factors were analyzed using multiple logistic regression. RESULTS: Of the 1096 participants, 609, 457, 138, and 90 had HE, CM, wheat, and peanut allergies, respectively. The median (interquartile range) age was 5.0 (2.3-8.6) years, 39% had completely eliminated allergenic food, and 24% had low-dose reactivity. The annualized AAR rate was 0.130 (0.109-0.153) in all sub-cohorts. Moderate and severe symptoms occurred in 50% and 0.7%, respectively, of children who experienced AAR. Multiple logistic regression revealed that low-dose reactivity was a significant risk factor for AAR in the overall and CM cohorts, respectively (p < .001 and p = .036). CONCLUSION: In this single-center study in Japan, the annualized AAR rate was relatively low during the COVID-19 pandemic; however, half of the participants with AAR had moderate to severe symptoms. Especially in the case of low-dose reactivity, children would require careful AAR risk management.


Sujet(s)
Allergènes , Hypersensibilité alimentaire , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Allergènes/immunologie , Allergènes/effets indésirables , Peuples d'Asie de l'Est , Hypersensibilité alimentaire/épidémiologie , Hypersensibilité alimentaire/immunologie , Hypersensibilité immédiate/épidémiologie , Hypersensibilité immédiate/étiologie , Hypersensibilité immédiate/immunologie , Immunoglobuline E/sang , Immunoglobuline E/immunologie , Japon/épidémiologie , Prévalence , Facteurs de risque
7.
Contact Dermatitis ; 91(2): 112-118, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38840483

RÉSUMÉ

BACKGROUND: Mainly women work as foot care specialists (FCS). They are at risk to develop occupational dermatitis (OD). OBJECTIVES: The objective of this study is to describe the contact sensitisation pattern of female FCS with OD. METHODS: In a retrospective study, patch test and clinical data collected by the Network of Departments of Dermatology (IVDK) from 2008 to 2022 were analysed. Data of 116 female FCS with OD were compared with data of 13 930 female patients with OD working in other professions and 78 612 female patients without OD. RESULTS: Hand dermatitis (93.1%) was significantly more common and face dermatitis (0.9%) significantly less common in female FCS with OD compared to other female patients with or without OD. Frequent suspected allergen sources were disinfectants, gloves, leave-on and nail cosmetics. Occlusion and wetness were important co-factors. The most common diagnoses were irritant contact dermatitis (26.7%) and allergic contact dermatitis (21.6%). No sensitisation to any of the baseline series allergens was significantly more frequent in female FCS with OD than in the two control groups. However, sensitisations to allergens which FCS are abundantly exposed to, including fragrances, preservatives, rubber ingredients and disinfectants, were most common. CONCLUSIONS: FCS should be aware of the OD risk and prevention should be promoted.


Sujet(s)
Eczéma de contact allergique , Dermatite irritative , Dermatite professionnelle , Dermatoses de la main , Tests épicutanés , Humains , Femelle , Dermatite professionnelle/épidémiologie , Dermatite professionnelle/étiologie , Dermatite professionnelle/diagnostic , Eczéma de contact allergique/étiologie , Eczéma de contact allergique/épidémiologie , Eczéma de contact allergique/diagnostic , Études rétrospectives , Adulte , Adulte d'âge moyen , Études cas-témoins , Dermatoses de la main/épidémiologie , Dermatoses de la main/étiologie , Dermatite irritative/épidémiologie , Dermatite irritative/étiologie , Allergènes/effets indésirables , Dermatoses faciales/épidémiologie , Dermatoses faciales/étiologie , Cosmétiques/effets indésirables , Désinfectants/effets indésirables , Gants de protection/effets indésirables , Dermatoses du pied/épidémiologie
8.
Contact Dermatitis ; 91(3): 177-185, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38945918

RÉSUMÉ

BACKGROUND: Fragrance substances are a frequent cause of contact allergy worldwide. Fragrance exposure varies by sex, age and possibly country, influenced by cosmetic availability, environmental conditions and cultural practices. OBJECTIVES: To systematically review and gather prevalence of sensitization to fragrance mix I (FM I) and fragrance mix II (FM II) in consecutively patch tested European dermatitis patients. METHOD: A total of 4134 publications on patch test results of European dermatitis patients, published from 1981 to 2022, were systematically reviewed according to a previously registered and published PROSPERO protocol. RESULTS: Eighty-four eligible original articles were analysed. Overall prevalence of sensitization to fragrance mix I (FM I) was 6.81% (95% CI: 6.37-7.28), and FM II was 3.64% (95% CI: 3.3-4.01). Sensitization to FM I was most prevalent in Central and Eastern Europe and to FM II in Western Europe. No clear time trends were observed. Among paediatric dermatitis patients, sensitization prevalence for FM I and FM II was 4.09% (95% CI: 3.37-4.96) and 2.17% (95% CI: 1.53-3.07). CONCLUSION: The frequency of positive patch test results for both FMI and FMII remains high. Sensitization is also prevalent among children. Enhanced regulation and labelling of cosmetic products play a vital role in averting exposure and sensitization to fragrance allergens.


Sujet(s)
Eczéma de contact allergique , Tests épicutanés , Parfum , Humains , Eczéma de contact allergique/étiologie , Eczéma de contact allergique/épidémiologie , Eczéma de contact allergique/diagnostic , Europe/épidémiologie , Parfum/effets indésirables , Prévalence , Allergènes/effets indésirables , Cosmétiques/effets indésirables
9.
Environ Res ; 257: 119346, 2024 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-38838752

RÉSUMÉ

BACKGROUND: Asthma exacerbations are an important cause of emergency department visits but much remains unknown about the role of environmental triggers including viruses and allergenic pollen. A better understanding of spatio-temporal variation in exposure and risk posed by viruses and pollen types could help prioritize public health interventions. OBJECTIVE: Here we quantify the effects of regionally important Cupressaceae pollen, tree pollen, other pollen types, rhinovirus, seasonal coronavirus, respiratory syncytial virus, and influenza on asthma-related emergency department visits for people living near eight pollen monitoring stations in Texas. METHODS: We used age stratified Poisson regression analyses to quantify the effects of allergenic pollen and viruses on asthma-related emergency department visits. RESULTS: Young children (<5 years of age) had high asthma-related emergency department rates (24.1 visits/1,000,000 person-days), which were mainly attributed to viruses (51.2%). School-aged children also had high rates (20.7 visits/1,000,000 person-days), which were attributed to viruses (57.0%), Cupressaceae pollen (0.7%), and tree pollen (2.8%). Adults had lower rates (8.1 visits/1,000,000 person-days) which were attributed to viruses (25.4%), Cupressaceae pollen (0.8%), and tree pollen (2.3%). This risk was spread unevenly across space and time; for example, during peak Cuppressaceae season, this pollen accounted for 8.2% of adult emergency department visits near Austin where these plants are abundant, but 0.4% in cities like Houston where they are not; results for other age groups were similar. CONCLUSIONS: Although viruses are a major contributor to asthma-related emergency department visits, airborne pollen can explain a meaningful portion of visits during peak pollen season and this risk varies over both time and space because of differences in plant composition.


Sujet(s)
Asthme , Service hospitalier d'urgences , Pollen , Pollen/effets indésirables , Asthme/épidémiologie , Humains , Service hospitalier d'urgences/statistiques et données numériques , Enfant , Enfant d'âge préscolaire , Adulte , Adolescent , Jeune adulte , Adulte d'âge moyen , Texas/épidémiologie , Nourrisson , Femelle , Mâle , Sujet âgé , Virus/isolement et purification , Allergènes/effets indésirables , Polluants atmosphériques/analyse ,
10.
Medicina (Kaunas) ; 60(6)2024 Jun 08.
Article de Anglais | MEDLINE | ID: mdl-38929571

RÉSUMÉ

Cannabis allergy is a relatively new phenomenon described in the 1970s. Its increased frequency has been observed over the last years due to the increasing therapeutic and recreational use of cannabis-based products. Sensitization possibly leading to allergy symptoms can occur not only through the smoking of cannabis, but also through ingestion, the inhalation of pollen, or direct contact. The severity of symptoms varies from benign pruritus to anaphylaxis. There is scant information available to support clinicians throughout the entire therapeutic process, starting from diagnosis and ending in treatment. In this review, we present six cases of patients in whom molecular in vitro testing revealed sensitization to cannabis extract and/or cannabis-derived nsLTP molecules (Can s 3). Based on these cases, we raise important questions regarding this topic. The article discusses current proposals and highlights the importance of further research not only on cannabis allergy but also on asymptomatic sensitization to cannabis allergens, which may be ascertained in some percentage of the population.


Sujet(s)
Allergènes , Cannabis , Immunoglobuline E , Humains , Allergènes/immunologie , Allergènes/effets indésirables , Cannabis/effets indésirables , Hypersensibilité/immunologie , Hypersensibilité/diagnostic , Immunoglobuline E/sang , Immunoglobuline E/immunologie
11.
Arch Dermatol Res ; 316(7): 372, 2024 Jun 08.
Article de Anglais | MEDLINE | ID: mdl-38850385

RÉSUMÉ

Occupational dermatoses impose a significant socioeconomic burden. Allergic contact dermatitis related to occupation is prevalent among healthcare workers, cleaning service personnel, individuals in the beauty industry and industrial workers. Among risk factors, the exposure to preservatives is frequent, since they are extensively added in products for occupational use. The goal of this study is to investigate the contact allergy patterns in order to understand the linkage among hypersensitivity to preservatives, occupational profiles, patients' clinical and demographic characteristics. Patch test results were collected from monosensitized patients to Formaldehyde 2%, KATHON 0.02%, thimerosal 0.1%, and MDBGN 0.5%; information was also collected for an extended MOAHLFA (Male-Occupational-Atopic-Hand-Leg-Face-Age) index. To assess the relationship between allergen group and occupational-related ACD, the chi-square test for independence was utilized. To uncover underlying relationships in the data, multiple correspondence analysis (MCA) and categorical principal components analysis (CATPCA), which are machine learning approaches, were applied. Significant relationships were found between allergen group and: occupation class, atopy, hand, leg, facial, trunk, neck, head dermatitis, clinical characteristics, ICDRG 48 h and ICDRG 72 h clinical evaluation. MCA and CATPCA findings revealed a link among allergen group, occupation class, patients' demographic and clinical characteristics, the MOAHLFA index, and the ICDRG scores. Significant relationships were identified between the allergen group and various manifestations of dermatitis. The utilization of machine learning techniques facilitated the discernment of meaningful patterns in the data.


Sujet(s)
Eczéma de contact allergique , Dermatite professionnelle , Apprentissage machine , Tests épicutanés , Conservateurs pharmaceutiques , Humains , Dermatite professionnelle/diagnostic , Dermatite professionnelle/étiologie , Dermatite professionnelle/épidémiologie , Mâle , Femelle , Eczéma de contact allergique/diagnostic , Eczéma de contact allergique/épidémiologie , Eczéma de contact allergique/immunologie , Eczéma de contact allergique/étiologie , Adulte , Adulte d'âge moyen , Conservateurs pharmaceutiques/effets indésirables , Formaldéhyde/effets indésirables , Allergènes/immunologie , Allergènes/effets indésirables , Thiomersal/effets indésirables , Jeune adulte , Exposition professionnelle/effets indésirables , Exposition professionnelle/statistiques et données numériques , Facteurs de risque
12.
Contact Dermatitis ; 91(2): 91-103, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38812248

RÉSUMÉ

Patch testing is the only clinically applicable diagnostic method for Type IV allergy. The availability of Type IV patch test (PT) allergens in Europe, however, is currently scarce. This severely compromises adequate diagnostics of contact allergy, leading to serious consequences for the affected patients. Against this background, the European Society of Contact Dermatitis (ESCD) has created a task force (TF) (i) to explore the current availability of PT substances in different member states, (ii) to highlight some of the unique characteristics of Type IV vs. other allergens and (iii) to suggest ways forward to promote and ensure availability of high-quality patch testing substances for the diagnosis of Type IV allergies throughout Europe. The suggestions of the TF on how to improve the availability of PT allergens are supported by the ESCD, the European Academy of Allergy and Clinical Immunology, and the European Academy of Dermatology and Venereology and intend to provide potential means to resolve the present medical crisis.


Sujet(s)
Allergènes , Eczéma de contact allergique , Dermatite professionnelle , Tests épicutanés , Humains , Tests épicutanés/méthodes , Europe , Eczéma de contact allergique/diagnostic , Eczéma de contact allergique/étiologie , Allergènes/effets indésirables , Dermatite professionnelle/diagnostic , Dermatite professionnelle/étiologie , Sociétés médicales , Comités consultatifs
13.
Allergol Immunopathol (Madr) ; 52(3): 73-77, 2024.
Article de Anglais | MEDLINE | ID: mdl-38721958

RÉSUMÉ

For the first time 15 years ago, tablet allergen immunotherapy (T-AIT) formulations were approved by regulatory agencies for treating allergic rhinitis caused by grass pollen in adults and children aged >5 years. Extensive evidences existed about effectiveness and safety of AIT. However, the safety profile is particularly compelling in children. Generally, T-AIT causes local reactions, mostly in the oral cavity, that are usually mild-to-moderate and often self-resolving. However, systemic allergic reactions are also observed with T-AIT, anaphylaxis representing the most fearsome adverse event, considering that it occurs in subjects treated for allergic rhinitis. Therefore, we conducted a literature search of patients reporting anaphylaxis because of T-AIT. Nine cases of anaphylactic reactions were reported in literature. Notably, no death was reported using T-AIT. This outcome was very important as it underscored the substantial safety of T-AIT. However, T-AIT deserves careful attention, mainly in the pediatric population. In this regard, after the first report of anaphylactic reaction at the first administration of T-AIT, manufacturers recommended that the first dose should be administered in a medical facility in the presence of staff with experience in managing anaphylaxis and the patient should be observed for at least 30 min. Interestingly, reported anaphylactic reactions were due to grass pollen extracts, with no report concerning other allergen extracts. However, it is relevant to note that anaphylactic reactions because of T-AIT are not reported in recent years.


Sujet(s)
Allergènes , Anaphylaxie , Désensibilisation immunologique , Comprimés , Humains , Anaphylaxie/thérapie , Anaphylaxie/étiologie , Anaphylaxie/immunologie , Désensibilisation immunologique/méthodes , Désensibilisation immunologique/effets indésirables , Allergènes/immunologie , Allergènes/administration et posologie , Allergènes/effets indésirables , Enfant , Pollen/immunologie , Pollen/effets indésirables , Poaceae/immunologie , Poaceae/effets indésirables , Rhinite allergique saisonnière/thérapie , Rhinite allergique saisonnière/immunologie , Adulte , Rhinite allergique/thérapie , Rhinite allergique/immunologie , Enfant d'âge préscolaire
15.
Contact Dermatitis ; 91(3): 203-211, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38778718

RÉSUMÉ

BACKGROUND: Earlier studies suggested a potential association between tobacco smoking and nickel sensitization, but little is known about other contact allergens. OBJECTIVES: To investigate the association of smoking status and contact sensitizations as well as subtypes of dermatitis, and to analyse the sensitization profiles of tobacco smokers. PATIENTS AND METHODS: Within the Information Network of Departments of Dermatology (IVDK), we performed a cross-sectional multicentre pilot study comprising 1091 patch-tested patients from 9 departments, comparing 541 patients with a history of cigarette smoking (281 current and 260 former smokers) with 550 never-smokers. RESULTS: We could not confirm the previously reported association between nickel sensitization and tobacco smoking. Moreover, sensitizations to other allergens, including colophony, fragrance mix I, Myroxylon pereirae and formaldehyde, were not increased in cigarette smokers compared with never smokers. Hand dermatitis (50.6% vs. 33.6%) and occupational cause (36.2% vs. 22.5%) were significantly more frequent among cigarette smokers compared with never-smokers as shown by non-overlapping 95% confidence intervals. CONCLUSIONS: Although our study does not allow a firm conclusion on whether smoking status contributes to certain contact sensitizations, it confirms an association of smoking with hand dermatitis and occupational cause.


Sujet(s)
Eczéma de contact allergique , Dermatite professionnelle , Tests épicutanés , Humains , Études transversales , Projets pilotes , Eczéma de contact allergique/étiologie , Eczéma de contact allergique/épidémiologie , Eczéma de contact allergique/diagnostic , Mâle , Femelle , Adulte d'âge moyen , Adulte , Dermatite professionnelle/épidémiologie , Dermatite professionnelle/étiologie , Dermatoses de la main/épidémiologie , Dermatoses de la main/étiologie , Nickel/effets indésirables , Fumer du tabac/effets indésirables , Fumer du tabac/épidémiologie , Allergènes/effets indésirables , Sujet âgé
16.
Contact Dermatitis ; 91(2): 139-145, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38783163

RÉSUMÉ

BACKGROUND: Chemical hair relaxers are widely utilized by black women, yet little research exists on the allergens present in these products. OBJECTIVE: This study aims to investigate allergen prevalence in the most popular chemical hair relaxers. METHODS: We analysed 41 products from five major retailers, identifying allergens through ingredient lists and comparing them to the 2020 American Contact Dermatitis Group Core allergen series. RESULTS: The most common contact allergens in chemical relaxers include propylene glycol, cetyl steryl alcohol, fragrance, D/L-a-tocopherol, tea tree oil and cocamidopropyl betaine. CONCLUSION: Understanding allergen exposure in products used by individuals with textured hair is needed for managing contact dermatitis in diverse populations. This analysis underscores the presence of potential allergens in hair relaxers, emphasizing the importance of dermatologists' awareness and patient scrutiny of ingredient lists.


Sujet(s)
Allergènes , Eczéma de contact allergique , Produits capillaires , Humains , Produits capillaires/effets indésirables , Produits capillaires/composition chimique , Allergènes/effets indésirables , Allergènes/analyse , Eczéma de contact allergique/étiologie , Bétaïne/analogues et dérivés , Bétaïne/effets indésirables , Bétaïne/analyse , Huile d'arbre à thé/effets indésirables , Huile d'arbre à thé/analyse , Parfum/effets indésirables , Parfum/analyse , Propylène glycol/effets indésirables , Propylène glycol/analyse , Femelle
18.
Pediatr Dermatol ; 41(4): 651-653, 2024.
Article de Anglais | MEDLINE | ID: mdl-38676435

RÉSUMÉ

BACKGROUND: Considering consumer trends toward the use of "clean" personal care products and increasing recognition of childhood allergic contact dermatitis, we sought to characterize the allergen profile of such children's products. METHODS: Ingredients of baby washes/shampoos, bubble baths, and moisturizers identified using the "Clean Baby" filter on Target®'s online marketplace were analyzed for relevant pediatric contact allergens. RESULTS: Product compositions declared fragrance in 82% of products, Compositae in 46%, cocamidopropyl betaine in 45%, glucosides in 37%, propylene glycol in 12%, lanolin in 1%, and no allergens in 9%-methylisothiazolinone and formaldehyde were not found. CONCLUSION: Children are greatly impacted by atopic dermatitis and skin barrier dysfunction, which underscores a need for greater public awareness of sensitizing and irritating ingredients, particularly regarding pediatric personal care products.


Sujet(s)
Allergènes , Eczéma de contact allergique , Humains , Allergènes/effets indésirables , Allergènes/analyse , Eczéma de contact allergique/étiologie , Enfant , Cosmétiques/effets indésirables , Cosmétiques/composition chimique , Sécurité des produits de consommation , Propylène glycol/effets indésirables , Propylène glycol/analyse
20.
Contact Dermatitis ; 91(1): 45-53, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38602297

RÉSUMÉ

BACKGROUND: Allergic contact dermatitis (ACD) from rubber glove usage is usually caused by rubber additives such as the accelerators. However, in analyses of the suspected gloves, ordinary rubber allergens are not always found. Accelerator-free rubber gloves are available, but some patients with accelerator allergy do not tolerate them and might also be patch test positive to them. OBJECTIVES: To identify and chemically characterize a new allergen, 2-cyanoethyl dimethyldithiocarbamate (CEDMC), in rubber gloves. We describe two patient cases: patient 1 that led us to the identification of CEDMC and patient 2 with occupational ACD caused by CEDMC. METHODS: The patients were examined with patch testing including baseline and rubber series, and their own rubber gloves. High-performance liquid chromatography (HPLC) was used for chemical analysis of rubber gloves. The allergen was synthesized and identified by nuclear magnetic resonance, mass spectrometry and infrared spectrometry, and tested on patient 2. RESULTS: CEDMC was identified by HPLC in a nitrile glove associated with hand eczema in patient 1. Patient 2 whose nitrile gloves contained CEDMC was patch test positive to CEDMC. CONCLUSIONS: CEDMC is a new contact allergen in nitrile gloves and probably forms during vulcanization from residual monomer acrylonitrile and rubber additives.


Sujet(s)
Eczéma de contact allergique , Dermatite professionnelle , Gants de protection , Nitriles , Tests épicutanés , Humains , Eczéma de contact allergique/étiologie , Eczéma de contact allergique/diagnostic , Gants de protection/effets indésirables , Dermatite professionnelle/étiologie , Dermatite professionnelle/diagnostic , Nitriles/effets indésirables , Diméthyl-dithiocarbamate/effets indésirables , Mâle , Dermatoses de la main/induit chimiquement , Femelle , Adulte d'âge moyen , Allergènes/effets indésirables , Allergènes/analyse , Adulte , Chromatographie en phase liquide à haute performance , Acide diéthyl-dithiocarbamique/effets indésirables , Acide diéthyl-dithiocarbamique/composition chimique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE